- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4409 - Non-condensed pyridinesHydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
Patent holdings for IPC class A61K 31/4409
Total number of patents in this class: 1081
10-year publication summary
|
102
|
69
|
89
|
86
|
97
|
75
|
71
|
58
|
58
|
39
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Lenz Therapeutics Operations, Inc. | 49 |
21 |
| RedHill Biopharma Ltd. | 85 |
18 |
| Massachusetts Institute of Technology | 10273 |
16 |
| Insmed Incorporated | 282 |
14 |
| University of Rochester | 1339 |
12 |
| Bristol-myers Squibb Company | 4748 |
11 |
| Allergan, Inc. | 2159 |
11 |
| The Penn State Research Foundation | 1621 |
11 |
| Theravance Biopharma R&D IP, LLC | 360 |
11 |
| Centre National de La Recherche Scientifique | 11055 |
10 |
| The Regents of the University of California | 20802 |
9 |
| The General Hospital Corporation | 4869 |
9 |
| Purdue Research Foundation | 3929 |
9 |
| Children's Medical Center Corporation | 1962 |
9 |
| Enanta Pharmaceuticals, Inc. | 421 |
9 |
| Senju Pharmaceutical Co., Ltd. | 224 |
9 |
| City of Hope | 1040 |
8 |
| The Trustees of Columbia University in the City of New York | 3644 |
7 |
| The Doshisha | 229 |
7 |
| Kyoto Prefectural Public University Corporation | 258 |
7 |
| Other owners | 863 |